Last $51.05 USD
Change Today -1.11 / -2.13%
Volume 3.9M
TEVA On Other Exchanges
Symbol
Exchange
New York
OTC US
Mexico
Tel Aviv
Frankfurt
As of 8:04 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - teva pharmaceutical-sp adr (TEVA)

Name (Connections)Board RelationshipsTitleKey Developments
Erez Vigodman 12 RelationshipsChief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee 
Ory Slonim 12 RelationshipsDirector, Chairman of Corporate Responsibility Committee, Member of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee and Member of Audit Committee 
Joseph Nitzani 12 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee 
Moshe Many Ph.D., M.D. 36 RelationshipsDirector, Vice Chairman of Science & Technology Committee, Member of Audit Committee and Member of Corporate Governance & Nominating Committee 

Compensation Committee* - teva pharmaceutical-sp adr (TEVA)

Name (Connections)Board RelationshipsTitle
Roger Abravanel 83 RelationshipsDirector and Member of Human Resources & Compensation Committee
Richard Lerner M.D. 227 RelationshipsDirector, Member of Science & Technology Committee, Member of Human Resources & Compensation Committee and Member of Corporate Governance & Nominating Committee
Joseph Nitzani 12 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee
Dan Propper 24 RelationshipsDirector, Chairman of Corporate Governance & Nominating Committee and Member of Human Resources & Compensation Committee
Ory Slonim 12 RelationshipsDirector, Chairman of Corporate Responsibility Committee, Member of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee and Member of Audit Committee
Key PositionIndustry Range
No Compensation vs Industry data is available for TEVA.
52 Week Price Performance
Share price activity for TEVA PHARMACEUTICAL-SP ADR (TEVA)
TEVA
Industry Average

Nominating Committee* - teva pharmaceutical-sp adr (TEVA)

Name (Connections)Board RelationshipsTitleKey Developments
Amir Elstein 42 RelationshipsVice Chairman, Member of Corporate Governance & Nominating Committee, Member of Corporate Responsibility Committee and Member of Finance & Invesment CommitteeTeva Pharmaceutical Industries Limited Announces Board Changes
06/18/14
Ory Slonim 12 RelationshipsDirector, Chairman of Corporate Responsibility Committee, Member of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee and Member of Audit CommitteeTeva Pharmaceutical Industries Limited Announces New Organizational Structure, Effective July 1, 2014; Announces Executive Changes, Effective July 1, 2014
06/2/14
Dan Propper 24 RelationshipsDirector, Chairman of Corporate Governance & Nominating Committee and Member of Human Resources & Compensation CommitteeTeva Pharmaceutical Industries Announces Executive Changes, Effective from February 11, 2014
01/9/14
Joseph Nitzani 12 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility CommitteeTeva Pharmaceutical Industries Limited Announces Executive Changes, Effective January 1, 2014
12/10/13
Moshe Many Ph.D., M.D. 36 RelationshipsDirector, Vice Chairman of Science & Technology Committee, Member of Audit Committee and Member of Corporate Governance & Nominating CommitteeTeva Pharmaceutical Industries Limited Announces Executive Changes
10/30/13
Richard Lerner M.D. 227 RelationshipsDirector, Member of Science & Technology Committee, Member of Human Resources & Compensation Committee and Member of Corporate Governance & Nominating Committee

Corporate Governance Committee* - teva pharmaceutical-sp adr (TEVA)

Name (Connections)Board RelationshipsTitle
Amir Elstein 42 RelationshipsDirector and Member of Human Resources & Compensation Committee
Richard Lerner M.D. 227 RelationshipsDirector, Member of Science & Technology Committee, Member of Human Resources & Compensation Committee and Member of Corporate Governance & Nominating Committee
Moshe Many Ph.D., M.D. 36 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee
Joseph Nitzani 12 RelationshipsDirector, Chairman of Corporate Governance & Nominating Committee and Member of Human Resources & Compensation Committee
Dan Propper 24 RelationshipsDirector, Chairman of Corporate Responsibility Committee, Member of Corporate Governance & Nominating Committee, Member of Human Resources & Compensation Committee and Member of Audit Committee
Ory Slonim 12 Relationships--
TEVA and Competitor
Insiders vs. External
Board
8%
92%
Teva Pharmaceutical Industries Limited
9%
91%
Abbott Laboratories
8%
92%
Baxter International Inc.
13%
87%
Eli Lilly and Company
50%
50%
Johnson Matthey plc
8%
92%
Covidien plc
Insiders
External Board Members

Finance Committee* - teva pharmaceutical-sp adr (TEVA)

Name(Connections)Board RelationshipsTitle
Galia Maor 31 RelationshipsDirector, Chairman of Finance & Invesment Committee and Member of Corporate Responsibility Committee
Joseph Nitzani 12 RelationshipsStatutory Independent Director, Chairman of Audit Committee, Vice Chairman of Human Resources & Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Finance & Invesment Committee and Member of Corporate Responsibility Committee
Yitzhak Peterburg M.D., Dr.P.H., MSc 33 RelationshipsDirector, Vice Chairman of Finance & Invesment Committee and Member of Science & Technology Committee
Erez Vigodman 12 RelationshipsChief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Debt To Total Capitalization32.1x
It is important for the finance committee to know when to issue debt or equity.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $51.05 USD -1.11

TEVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $43.40 USD -0.19
Baxter International Inc $72.07 USD -0.47
Covidien PLC $90.40 USD -0.45
Eli Lilly & Co $66.08 USD -0.45
Johnson Matthey PLC 3,096 GBp -25.00
View Industry Companies
 

Industry Analysis

TEVA

Industry Average

Valuation TEVA Industry Range
Price/Earnings 17.2x
Price/Sales 2.2x
Price/Book 1.9x
Price/Cash Flow 19.2x
TEV/Sales 1.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.